---
$id: https://graph.org.ai/products/commodity/51131750
$type: Product
source: UNSPSC
code: "51131750"
title: "Lotrafiban hydrochloride"
class: "51131700"
classTitle: "Thrombolytic drugs and platelet aggregation inhibitors"
family: "51130000"
familyTitle: "Hematolic drugs"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Lotrafiban hydrochloride

**UNSPSC Code**: 51131750
**Class**: [Thrombolytic drugs and platelet aggregation inhibitors](Thrombolytic drugs and platelet aggregation inhibitors.mdx)
**Family**: [Hematolic drugs](../Hematolic drugs.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an antiplatelet agent C23H32N4O4.ClH, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier GSV7V79C63, chemically known as (s)-2,3,4,5-tetrahydro-4-methyl-3-oxo-7-((4-(4-piperidyl)piperidino)carbonyl)-1h-1,4-benzodiazepine-2-acetic acid, monohydrochloride, but more generally known as lotrafiban hydrochloride, which bears US NIH Compound Identifier 80275. Most nations, for tariff and trade purposes, schedule lotrafiban hydrochloride under HS 29333999 and SITC 51574. As of Q4 2014, LOTRAFIBAN HYDROCHLORIDE remains US FDA's Preferred Term for this commodity. Lotrafiban hydrochloride bears US NLM identifiers UMLS ID C1259239 and NCI Concept Code C81572. SMILES: CN1CC2CC(CCC2N[C@H](C1=O)CC(=O)O)C(=O)N3CCC(CC3)C4CCNCC4.CL.

